Imperative Care, Inc.

Imperative Care, Inc. is a privately held medical technology company founded in 2015. Headquartered in Campbell, California, the company develops and manufactures medical devices focused on the treatment of vascular diseases, particularly stroke and other conditions caused by blood clots. As a private entity, it is not publicly traded. Various sources report employee counts in the range of 300 to 400.

Imperative Care is an operating company that develops and commercializes technologies for treating ischemic and hemorrhagic strokes, as well as other vascular conditions like pulmonary embolisms. Its product portfolio includes systems for thrombectomy (clot removal). Major product lines include the Zoom Stroke System, a complete system for clot removal in ischemic stroke patients, and the Symphony and Prodigy Thrombectomy Systems for treating venous thromboembolism and acute limb ischemia. The company is also developing the Telos robotic platform, an endovascular robotics system designed to improve precision and access to care.

As an operating company, Imperative Care's patent litigation profile shows it as a defendant. The company has been named as a defendant in one tracked case and has not appeared as a plaintiff. This posture is consistent with a technology manufacturer being sued by a competitor rather than an entity that primarily asserts patents. The single tracked case was filed in the U.S. District Court for the Northern District of California, a common venue for technology-related disputes.

The notable tracked case is Inari Medical, Inc. v. Imperative Care, Inc. et al., filed in May 2024. Inari Medical, a competitor in the thrombectomy device market, sued Imperative Care for patent infringement related to its medical devices used to remove blood clots. Court records indicate the dispute involves multiple patents concerning thrombectomy systems. Imperative Care has challenged the validity of Inari's patents, including through an inter partes review (IPR) proceeding at the Patent Trial and Appeal Board.